Dr. Dana Sleiman
Scope of Practice
- Diabetes & Obesity
- Functional Medicine
- Osteoporosis & calcium metabolism
- Pituitary and Adrenal Diseases
- Polycystic Ovary Syndrome (PCOS) & Hormonal Imbalances
- Thyroid disease
Highlights
Academic Achievements
33+
Conferences
9+
Research
5+
Pro Courses
Community Outreach Activities/Achievements
- Featured in several TV interviews on local and regional channels: presented and participated in around 100 medical and social events
- Participated in raising social & public awareness for Diabetes, Obesity and other endocrinological disorders as a Co-Founder of the Development Association for Arab Leadership & Innovation, Beirut, Lebanon
Health Care Profession Achievements
- 10 Years of Experience
Experience & Education
- Endocrinology consultant, Beirut Lebanon
- Functional Medicine Certificate -Institute of Functional Medicine (IFM) / USA
- Specialty in Endocrinology & Diabetes Certificate –Royal College of Physicians London / England
- Specialty in Endocrinology and Metabolism -Fellowship Program in Endocrinology & Metabolism Department of Endocrinology -American University of Beirut Medical Center (AUBMC) Beirut
- Specialty in Internal Medicine Department of Internal Medicine Residency Program in Internal Medicine -American University of Beirut Medical Center (AUBMC) -Beirut
- Doctor of Medicine (MD) School of Medicine American University of Beirut (AUB) -Beirut
Certifications
- Co-Founder –Development Association for Arab Leadership & Innovation / Beirut
- Member –Lebanese Society of Endocrinology, Diabetes & Lipids
- Member –Lebanese Order of Physicians
- Member –Endocrine Society / USA
- Member –Health 2.0 NYC- The New York Health Care Innovation Group/ USA
- Member –Lebanese Society for Osteoporosis and Metabolic Bone Disorders / Beirut
- Former Member –Lebanese Red Cross, (Youth Section) / Beirut
Publications
- 12months,multicenter,non-interventional,prospective study to describe clinical outcomes after iGlarlixi initiation in patients with type 2 diabetes Research investigator 2020 {Sponsored by Sanofi}
- Effect of Mediterranean Diet in Diabetes Control & Cardiovascular Risk Modification A Systematic Review / Feb 2017 Authors: Dana Sleiman, Marwa R Al Badri & Sami T Azar {Child Health and Human Development – Frontiers}
- The effect of Magnesium Supplementation on Glucose Metabolism Reviewer of Randomized Controlled Trial - May 2016 {European Journal of Clinical Nutrition}
- {OSTEOS Newsletter- Winter 2013} Guest Editor {Lebanese Society of Osteoporosis and Metabolic Bone Disease}
- GLP (1) and macro vascular complications Authors Dana Sleiman and Sami T Azar / Jan 2012 {Journal of Diabetes and Metabolism}
- Multinational open label randomized active controlled 3 arm parallel groups 24 weeks’ study comparing combination of glimepiride and metformin versus glimepiride and metformin alone in patients with type two diabetes. Research co-investigator 2013 {Sponsored by Sanofi- Aventis}
- Diabetes: From Etiology to Complications Data Collector & Analyst – {Prepared for Ministry of Social Affairs Workshop} 2013
- GLP 1 and Macrovascular Complications Data Collector & Analyst – 2012 {Prepared for the Journal of Diabetes and Metabolism}